Normal view MARC view ISBD view

Electrical molecular switch addressed by chemical stimuli. [electronic resource]

By:

Audi, H

Contributor(s):

Publication details: Nanoscale May 2020Description: 10127-10139 p. digitalISSN:

2040-3372

Online resources:

Available from publisher's website

In: Nanoscale vol. 12

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

2441 [Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II)].
by Fernández, Óscar
2442 [Review of the novelties presented at the 2018 ECTRIMS Congress: 11th Post-ECTRIMS Meeting (I)].
by Fernandez, O
2443 [Review of the novelties presented at the 26th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I)].
by Fernández-Fernández, Oscar
2444 Prognostic value of antigen expression in multiple myeloma: a PETHEMA/GEM study on 1265 patients enrolled in four consecutive clinical trials.
by Arana, P
2445 Position paper on nasal obstruction: evaluation and treatment.
by Valero, A
2446 Subcutaneous advanced glycation end-products and lung function according to glucose abnormalities: The ILERVAS Project.
by Sánchez, E
2447 Phenotypic identification of subclones in multiple myeloma with different chemoresistant, cytogenetic and clonogenic potential.
by Paíno, T
2448 Contaminating viral sequences in high-throughput sequencing viromics: a linkage study of 700 sequencing libraries.
by Asplund, M
2449 Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).
by Fernández, Óscar
2450 [Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS meeting (I)].
by Fernandez, O
2451 Analytical and clinical validation of a novel in-house deep-sequencing method for minimal residual disease monitoring in a phase II trial for multiple myeloma.
by Martinez-Lopez, J
2452 Review of the novelties presented at the 27th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).
by Fernandez, Oscar
2453 Review of the novelties from the 2014 ECTRIMS-ACTRIMS Joint Congress, presented at the 7th Post-ECTRIMS Meeting (II).
by Fernandez, O
2454 Competition between clonal plasma cells and normal cells for potentially overlapping bone marrow niches is associated with a progressively altered cellular distribution in MGUS vs myeloma.
by Paiva, B
2455 Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).
by Fernandez, O
2456 Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (I).
by Fernández, Óscar
2457 Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III).
by Fernández, Óscar
2458 Review of the novelties presented at the 28th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (II).
by Fernandez, O
2459 [Guidelines of the Spanish Society of Cardiology for clinical practice in exercise testing].
by Arós, F
2460 Development and psychometric validation of a brief comprehensive health status assessment scale in older patients with hematological malignancies: The GAH Scale.
by Bonanad, S